|
Volumn 11, Issue 23, 2003, Pages 5013-5023
|
Synthesis and biological evaluation of substituted quinolines: Potential treatment of protozoal and retroviral co-infections
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1 BROMO 2 (2 QUINOLYL)ETHYLENE;
1 QUINOL 2 YLPROPAN 1 OL;
1,1 DIBROMO 2 (2 QUINOLYL)ETHYLENE;
2 ETHYNYLQUINOLINE;
2 TRIMETHYLSILYLETHYNYLQUINOLINE;
2 VINYLQUINOLINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIPROTOZOAL AGENT;
ANTIRETROVIRUS AGENT;
MEGLUMINE ANTIMONATE;
NIFURTIMOX;
QUINOLINE DERIVATIVE;
SURAMIN;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
AFRICAN TRYPANOSOMIASIS;
ANIMAL CELL;
ANIMAL MODEL;
ANTIVIRAL ACTIVITY;
ARTICLE;
BONE MARROW CELL;
CHAGAS DISEASE;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SCREENING;
DRUG SYNTHESIS;
FEMALE;
FEMUR;
HAMSTER;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IC 50;
LEISHMANIA;
MOUSE;
MOUSE STRAIN;
NONHUMAN;
PERITONEUM MACROPHAGE;
PROTOZOAL INFECTION;
RETROVIRUS INFECTION;
SKIN LEISHMANIASIS;
STRUCTURE ACTIVITY RELATION;
T CELL LEUKEMIA;
TIBIA;
VISCERAL LEISHMANIASIS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 0242266523
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2003.09.007 Document Type: Article |
Times cited : (198)
|
References (23)
|